It was a great honor for me to be awarded with the European Academy of Neurology Research Experience Fellowship. During my Fellowship I was for six months (January 2019 to June 2019) at the Department of Neurology, St. Josef-Hospital, Ruhr University of Bochum, Bochum, Germany to perform the project “Transorbital Sonography in patients with Optic Neuritis”.
EAN Congress 2025 relocated to HELSINKI due to UN summit (dates remain 21-24 June)
September 20, 2024
Due to unforeseen developments, the 11th Congress of the European Academy of Neurology has been relocated and will now be held in Helsinki on June 21-24, 2025.
EAN co-hosting G7 side-event in Ancona, Italy, on 8 October
September 13, 2024
Upcoming Joint Sessions at Partner Societies’ Congresses
August 26, 2024
Latest Posts
-
-
Please find below recent articles from Swiss authors that have been published in the European Journal of Neurology.
-
“SILENTLY LOSING THE BRAIN – The enigma of small vessel disease” Come to Copenhagen for the next Brain Prize Meeting in November 2019. With international keynote speakers, including the 2019 prize winners, the Lundbeck Foundation Brain Prize Meeting aims to bring a broad range of researchers to discuss why small vessel disease has emerged as a major contributor to dementia, migraine and stroke worldwide.
-
EAN NewsInterviewsTop Articles
Interview with Maeve Cusack, Board Member of the European Institute for Women’s Health
September 1, 2019Founded in1996, the European Institute of Women’s Health (EIWH) is a non-governmental organisation (NGO) and registered charity. The Institute uses an evidence-based approach to advocate for equitable, sex- and gender-sensitivity in health policy, research, promotion, treatment and care. It also promotes biomedical and socio-economic research that addresses sex and gender-based differences to ensure access to quality treatment and care for women across their lifespan. -
Executive PageEAN NewsFeatured Slider
Executive Page: EAN Scientific Panels & changing of the guards – get involved
September 1, 2019It is my pleasure to introduce the backbone of our society, the Scientific Panels, to you in my role as the Scientific Committee Chair. EAN Scientific Panels cover a wide range of subspecialties and play a significant role in the EAN everyday activities. These member-led groups are a perfect opportunity to network with colleagues -
Paper of the MonthEAN NewsTop ArticlesFeatured Slider
Paper of the Month: Trial of galcanezumab in prevention of episodic cluster headache & Rimegepant, an oral calcitonin gene-related peptide receptor antagonist, for migraine
September 1, 2019For September 2019, we have selected two scientific papers with a common theme: Goadsby et al., Trial of galcanezumab in prevention of episodic cluster headache NEJM 2019; 381: 132-41, and Lipton et al., Rimegepant, an oral calcitonin gene-related peptide receptor antagonist, for migraine NEJM 2019; 381: 142-9. -
Switzerland is a beautiful country in the heart of Europe, stretching east to west from the lake of Constance to the lake of Geneva, and north to south from the river Rhine to the lago maggiore. Switzerland encompasses wonderful sceneries in the Alps, the middle lands and the Jura, which offer all kinds of outdoor activities in summer and winter, but also countless cultural events in his small but also metropolitan cities. Switzerland is a successful example that a multilingual and multicultural country can work. German, French, Italian and Roman are the national languages, and, with a population of 8.42 million inhabitants, Switzerland hosts more than 25% of foreign inhabitants from all over the world, all contributing to a beautiful, colorful and multicultural country, which regardless is deep-rooted in his traditions of independence, liberty, and direct democracy.
-
Breaking newsOther NewsTop Articles
Breaking News: Updated restrictions for Gilenya – multiple sclerosis medicine not to be used in pregnancy
August 23, 2019The European Medicines Agency has recommended that the multiple sclerosis medicine Gilenya (fingolimod) must not be used in pregnant women and in women able to have children who are not using effective contraception. If a woman becomes pregnant while using Gilenya, the medicine must be stopped and the pregnancy will have to be closely monitored. This is because the active substance in Gilenya, fingolimod, can harm the unborn baby and may cause birth defects. -
Cognitive functioning and multimodal neuroimaging in narcolepsy type 1
-
During the Assembly of Delegates at the Oslo Congress, Professor Deuschl acknowledged Professor Hannah Cock’s longstanding tribute to EAN and her outstanding achievements in the Education Committee.
-
EAN NewsResearchUncategorized
Introducing the Scientific Committee – Charlotte Cordonnier
August 1, 2019The Scientific Committee is fully committed to a great mission: To increase and share the best clinical knowledge and the cutting-edge information from translational research in all neurological fields. Main actions are i) to facilitate exchanges and synergies with the Scientific Panels ii) to support the Guideline Production Group (update and diffusion of expertise and best clinical practice), iii) to interact positively with other scientific societies with reciprocal exchanges and liaise with the European Affairs sub-Committee to increase the awareness of Neurology in Europe. -
Resident and Research FellowsFellowship reportsEducation cornerEducation
Research Fellowship Application Deadline: 31 August 2019
August 1, 2019The purpose is to support training and experience for European Neurologists in any area of basic or clinical or applied research in neuroscience. The research work must be carried out at a European academic neurological department outside the country of residence. All applications should demonstrate experience/training of clear value to the home department/individual beyond that available in their own countries/institutions. -
News from EAN member societiesOther News
READING RECOMMENDATIONS: NEWS FROM OTHER SOCIETIES
August 1, 2019News from other societies -
Ahead of discussions on the new Multiannual Financial Framework (EU Budget for 2021-2027) during the European Council Summit on 20-21 June, the BioMed Alliance together with the EU Health Coalition partners published a statement advocating for a more substantial EU research budget.
-
Other NewsPatients societies reports
News from Alzheimer Europe: Early Bird registrations for Conference reach all-time high
August 1, 2019Early Bird rates for the 29th Alzheimer Europe Conference (#29AEC) closed on 30 June 2019. Alzheimer Europe is delighted to announce that almost 600 delegates have already registered, with many more expected between now and close of online registrations, on 13 October 2019. The number of registrations so far has exceeded all previous years. Alzheimer Europe is excited to see everyone there, for what promises to be a diverse and engaging conference.